Physician profile
Michael Michel
NPI 1073794806
$30,519.06
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $6,779 · 2021: $1,057 · 2022: $555 · 2023: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $381.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $12,498.25 | 2019 | |
| Ethicon US, LLC | $8,965.20 | 2019-2023 | Linx Reflux Management System |
| Medical Device Business Services, INC. | $7,659.13 | 2019-2021 | |
| Endogastric Solutions, INC | $580.97 | 2021-2022 | |
| Intuitive Surgical, INC. | $242.11 | 2019 | |
| Lucid Diagnostics INC. | $162.43 | 2023 | |
| Medtronic, INC. | $127.66 | 2022-2023 | Endoflip |
| Davol INC. | $53.90 | 2022-2023 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $48.53 | 2022-2023 | |
| Tela Bio, INC. | $34.58 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $30.21 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.43 | 2021 | |
| Integra Lifesciences Corporation | $17.05 | 2020 | |
| Shire North American Group INC | $15.46 | 2019 | |
| Teleflex LLC | $13.92 | 2023 | Weck |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $13.52 | 2019 | |
| Olympus America INC. | $12.67 | 2021 | |
| Covidien Lp | $12.20 | 2019 | |
| Novo Nordisk INC | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Michel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.